NCT01652976 2021-01-05
FOLFOX-D
University of Florida
Phase 2 Completed
Clinical Trials
4 trialsNCT01395017 2016-04-08
LAPC
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2 Completed
NCT00544908 2015-10-05
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
City of Hope Medical Center
Phase 2 Terminated
NCT00474812 2015-05-05
Dasatinib in Treating Patients With Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed